Of the women in the 2017 study over age 75, 63% had a mammogram.
Welcome to Paper of the Week, which looks back at research and commentary from the past 25 years in The American Journal of Managed Care®, and why they matter today.
This week’s paper comes from 2017, when authors funded by the National Cancer Institute determined that mammogram practice patterns were not well aligned with evidence-based care. Of the women in the study over age 75, 63% had a mammogram.
A study released just this week has pinpointed the age at which mammography no longer benefits older women. Results from the Harvard School of Public Health, published in Annals of Internal Medicine, show no clear benefit for mammography in women over the age of 75.
For the 2017 study in The American Journal of Managed Care®, visit ajmc.com.
Elacestrant Shows Real-World Effectiveness in Metastatic Breast Cancers
December 11th 2024Patients with ER-positive/HER2-negative metastatic breast cancer who received elacestrant experienced a significant reduction in disease progression or death compared with standard-of-care endocrine therapy.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Age-Related Disparities in Long-Term Outcomes for ER+, HER2– Breast Cancer
November 23rd 2024Younger women with estrogen receptor (ER)–positive, HER2-negative breast cancer have significantly worse long-term outcomes, including higher rates of recurrence and metastasis, compared with older women.
Read More
Racial Inequities in Guideline-Adherent Breast Cancer Care and Timely Treatment
November 19th 2024Older non-Hispanic Black adults with early-stage breast cancer are less likely to receive timely treatment and guideline-concordant care, increasing their risk of death compared with non-Hispanic White women.
Read More